Should Hyatt Stock Observe A Correction Post Q4 Results?

After gaining 39% in the past quarter due to multiple vaccine approvals and momentum in broader markets, Hyatt stock (NYSE: H) remains 15% below pre-Covid highs. As fears surrounding the new strains of coronavirus weigh on travel demand, hotel occupancy rates are expected to reAfter gaining 39% in the past quarter due to multiple vaccine approvals and momentum in broader markets, Hyatt stock (NYSE: H) remains 15% below pre-Covid highs. As fears surrounding the new strains of coronavirus weigh on travel demand, hotel occupancy rates are expected to reRead MoreStocks,US Markets,InvestingStocks Feed